Hyperliquid's HYPE token is now available for trading on South Korea's major cryptocurrency exchanges Upbit and Bithumb, including direct trading against the Korean won (KRW). This expands HYPE's accessibility to a large retail market and enhances liquidity options. Both exchanges require deposits and withdrawals through HyperEVM, and Upbit imposed temporary trading restrictions at launch. The listings mark a strategic move for Hyperliquid to broaden HYPE's reach, though sustained trading volume and price impact remain to be seen.
Hyperliquid's HYPE token listing on South Korean exchanges Upbit and Bithumb provides context for cryptocurrency market activity. For readers following crypto, here is Pluang's market snapshot as of Nov 10, 2026 17:41 WIB: Among 50 major cryptocurrencies, 33 rose and 16 fell. Notably, Solar (SXP) dropped sharply by 46.27% to Rp37, contrasting with Harmony (ONE) which gained 32.50% to the same price but with a longer typical hold time of 153 days and a 58% sell order activity. Balancer (BAL) rose moderately by 11.14% to Rp16,297 with a typical hold time of 85 days.
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
ESET Research uncovered a sophisticated cyberespionage tool named Cereal, used by the Russia-aligned Turla group to spy on emails within Microsoft Exchange servers of governmental organizations in Kazakhstan and Romania. The tool stealthily collects ...
The global paracetamol market is projected to grow from $12.05 billion in 2026 to $15.39 billion by 2032, with a CAGR of 4.12%. Growth is driven by increasing demand for pain and fever management, expanded access to over-the-counter medicines, and in...
Registration is now open for Brand Licensing Expo 2027, scheduled for May 25-27 at Mandalay Bay, Las Vegas. The event, rebranded from Licensing Expo, features over 265 confirmed exhibitors including major brands like Amazon MGM Studios, Coca-Cola, an...
Trogenix, a clinical-stage precision oncology company, has appointed John Young as Chair and Josh Murray as Non-Executive Director to support its global strategy, commercial growth, and US expansion. John Young brings over 35 years of pharmaceutical ...
